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Abstract
General aspects of glaucoma: Glaucoma is a heterogeneous multi-factorial disease that is one of the main causes of 
blindness, along with degeneration of retinal ganglion cells and optic nerve atrophy.
Theories of pathogenesis: There are three theories of glaucoma pathogenesis: biomechanical, vascular, and biochemical.
Basic theory of the glymphatic system: The classical knowledge of cerebrospinal fluid circulation has been revised, 
and in 2012 a new concept of glial-perivascular – glymphatic perfusion of the brain parenchyma was introduced. Due 
to experimental and clinical studies, it is approved by many scientists, especially in relation to Alzheimer’s disease 
(AD), in which amyloid pathology is the result of dysfunction of the para-/perivascular transport/cleansing pathways.
Features of the optic nerve and the cribriform plate: The cribriform plate forms a barrier at the border of intraocular 
(IOP) and intracranial (ICP) pressures, thus affecting the para-/periarterial flow of cerebrospinal fluid to the optic nerve 
and retina, as well as the para-/perivenous cleansing outflow.
Morphofunctional evidence of an ocular glymphatic system: The presence of an ocular glymphatic system is con-
firmed by in vivo experiments with the transfer of labeled substances through para-/perivascular structures from the 
ventricular or subarachnoid space to the optic nerve and by postmortem morphology.
Clinical evidence for the glymphatic system hypothesis: There is some clinical, including case-based, and epidemio-
logical evidence for similarities between glaucomatous optic nerve/retinal injuries and AD, since both occur in the form 
of improper secretion of neurotoxic metabolites, and both are often diagnosed together.
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General aspects of glaucoma
Glaucoma is a huge medical, social and economic pro-
blem worldwide, as it is one of the main causes of irre-
versible blindness (Quigley 2006). According to WHO 
estimates, the number of people who have gone blind as 
a result of primary glaucoma is 4.5 million (12% of all 
people who suffer from blindness). Currently, the etio-
logy and pathogenesis of glaucoma remain insufficient-
ly studied for the development of an effective treatment. 
The controversies and obscure aspects of the disease are 
reflected in multiple concepts of the problem. Moreover, 
even the definition of glaucoma was not unified for a long 
time due to high heterogeneity, because up to 60 eye di-
seases can lead to glaucomatous damage of the nervous 
structures of the eye (Nesterov 2008). Despite this, the 
key feature of glaucoma can be defined as glaucoma op-
tical neuropathy (GON), which occurs as a result of de-
generation of the retinal ganglion neurons, followed by 
optic nerve injury and the appearance of corresponding 
visual defects (Weinreb 2004).
There are three main forms of primary glaucoma: 
open-angle, closed-angle, and mixed (Weinreb et al. 2014).
The open-angle form is characterized by preserving the 
angle of the anterior chamber of the eye, which gives free 
access of aqueous humor to the drainage zone. Resistance 
to fluid outflow is found in the trabecula, venous sinus of 
sclera (Schlemm’s canal), collector channels, and intras-
cleral plexus. This form of glaucoma is accompanied by 
an increased, and sometimes moderate, IOP. With mod-
erate IOP, normal-pressure glaucoma is identified sepa-
rately, occurring mainly in people over 35 years of age, as 
well as in people of Asian ethnic group.
The closed-angle form has a narrow angle of the an-
terior chamber of the eye due to the closure of the tra-
becula by the iris root, as a result of which a decrease 
in the outflow of intraocular fluid and, accordingly, a 
sharp increase in IOP are observed. This form of glau-
coma appears when the iris and cornea join at the pe-
riphery of the anterior chamber of the eye, which can 
be caused by various factors, pushing the iris into the 
corner of the eye. Primary closed-angle glaucoma oc-
curs in older people, because as a person ages, the lens 
of the eye continues to grow, so young people do not 
have a narrowing of the angle of the anterior chamber 
(AAC) of the eye. In addition to age, the risk factors for 
narrowing the AAC include ethnicity: Asians and Hin-
dus are at a higher risk, while Africans and Europeans 
are at a lower risk.
The mixed form manifests as a combination of the nar-
rowing of the AAC and disruption of the permeability of 
filtration channels for aqueous humor.
In addition to all these forms of primary glaucoma, 
there are also, though much less frequent, congenital, hy-
persecretory, low-pressure, and many other forms of sec-
ondary glaucoma.
Aim of study
The aim of this paper is to review the achievements in 
understanding glaucoma pathology based on the latest 
morphofunctional concepts of the transport systems of 
cerebral metabolites.
Theories of glaucoma pathogenesis
The pathogenesis of glaucoma raises many questions due 
to the presence of many contradictory studies that reveal 
the role of a large number of factors that affect the occur-
rence and development of glaucomatous processes. In this 
regard, various theories of pathogenesis were considered, 
of which there are three main ones: vascular, biomechani-
cal, and biochemical.
In the vascular theory of GON, the predominant role 
in pathogenesis is played by a decrease in the hemoper-
fusion of the eye, which leads to ischemia of the optic 
disk and retina. However, all the accumulated information 
does not give full account of this theory, since there is 
evidence of both hypertension as a serious risk factor for 
the development of GON (Bonomi et al. 2000; Yanagi et 
al. 2011) and hypotension, which strongly affects the de-
velopment of GON (Graham and Drance 1999; Tokunaga 
et al. 2004). At the same time, there is a hypothesis stating 
that the death of ganglion cells occurs as a result of the 
primary and secondary stroke of the retinal ganglion cells. 
For example, it is assumed that primary stroke occurs in 
the axons of ganglion cells at the level of the cribriform 
plate (Caprioli and Coleman 2010). In them there appear 
the conditions observed during ischemia-reperfusion and 
leading to damage to the mitochondrias, since the activa-
tion of oxidation processes with the release of free radicals 
occurs (Kyhn et al. 2009). Secondary damage is observed 
in disorders of autoregulation of the optic nerve circula-
tion and neurovascular interaction (Balaratnasingam et al. 
2010). To this day, questions concerning the physiology 
and pathophysiology of blood circulation of the eye re-
main open, which directly relates to the understanding of 
the vascular theory of glaucoma pathogenesis.
The mechanical theory suggests that GON may be the 
result of increased IOP, resulting in high-tension areas 
that cause displacement and deformation of the cribriform 
plate, compression of prelaminar tissue, and, as a result, 
loss of glial cells (Flammer et al. 2002). The reason for 
an increased IOP is an increase in resistance in the main 
structures of the eye fluid outflow – in the trabecular re-
ticulum and Schlemm’s canal (Zolotarev et al. 2013; Fan 
et al. 2015). According to (Iomdina et al. 2011), an impor-
tant role in the development of glaucomatous process is 
played by distorted elasticity of the fibrous capsule, which 
occurs due to abnormal acceleration of the aging process-
es as a result of pathological changes in the metabolism of 
one of the most important structural proteins of the sclera 
Research Results in Pharmacology 6(3): 1–7 3
– collagen. A number of studies have proven the effect of 
mechanical deformation of the collagenous structures of 
the cribriform plate on glaucomatous excavation of the 
optic nerve. For instance, in experiments on monkeys, it 
was found that a sharp rise in IOP did not cause changes 
in the cribriform plate (Blumenthal et al. 2009), whereas 
a long-term increased IOP leads to an increase in the dis-
tensibility of the sclera and to its deformation (Agapova 
et al. 2001; Pena et al. 2001; Golubnitschaja et al. 2004).
The theory is supported by the conclusions in (Minck-
ler et al. 1978; Levy et al. 1981; Jonas 2014) made as a 
result of experimental and clinical observations of the de-
pendence of a degree of glaucomatous defects of the visual 
field, a degree of the displacement of support structures, 
and electrophysiological indicators on the value of IOP.
Over the past few years, evidence about the possible 
role of biochemical mechanisms leading to glaucomatous 
neurodegeneration has been increasing in the literature. It 
includes the role of the effects of excitatory amino acids, 
caspases, protein kinases, oxygen free radicals, nitric ox-
ide, and tumor necrosis factor-alpha (Ahmad et al. 2013).
Studying the primary, secondary and terminal products 
of lipid peroxidation in the aqueous humor and drainage 
system of the eyes, Grzybowski A et al. (2019) found an 
increase in their concentrations in patients with glaucoma 
compared to the norm. Based on this, they made an as-
sumption that the destruction of trabecular tissue in primary 
open-angle glaucoma (POAG) occurs when two factors are 
combined: an abnormally high concentration of peroxidants 
in aqueous humor and a reduced activity of the antioxidant 
system in the tissues of the trabecula and Schlemm’s canal. 
Violation of the ratio between the formation and removal 
of lipid peroxidation metabolites in patients with primary 
glaucoma leads to changes in the permeability of cell mem-
branes and the molecular structure of cells. According to 
Yu. S. Zavadskaya and G. G. Karzhaubaeva, this is due to 
a deficiency of tocopherol, one of the leading endogenous 
antioxidants. The metabolic mechanisms involved in the oc-
currence and development of glaucoma also include pseudo-
exfoliative dystrophy in the anterior segment of the eye and 
impaired glycosaminoglycans metabolism (Ahmad 2016).
Main concept of the glymphatic 
system (GLS)
Since the study by Brinker, Morrison, and Kling (Brinker 
et al. 2014), which provided a detailed description of new 
ideas in molecular and cellular biology, as well as neuroi-
maging studies that indicate that the physiology of cere-
brospinal fluid (CSF) is much more complex than previ-
ously thought, the classical theory of CSF circulation has 
become more complex, and a new hypothesis has been 
proposed regarding CSF hydrodynamics. Recent research 
on the biology of CSF has revealed the importance of the 
so-called ”glymphatic system” in elimination of potentially 
neurotoxic products, including amyloid-β. The glymphatic 
system was first described by Iliff (Iliff et al. 2012), who 
first identified a brain-wide network of paravascular chan-
nels in mice, which they called the ”glymphatic” pathway, 
through which most of the subarachnoid cerebrospinal fluid 
recycles through the brain’s parenchyma, facilitating the 
clearance of interstitial solutes, including amyloid-β (Aß), 
from the brain. Although the glymphatic concept is also cal-
led into question and more research is needed to confirm 
its functional significance, one of its consequences is that 
glymphatic pathway dysfunction may contribute to insuffi-
cient Aß clearance in the pre-clinical stages of Alzheimer’s 
disease (AD) (Yang et al. 2013). It is believed that AD is 
caused by an imbalance between the production and excre-
tion of Aß, leading to the accumulation of this protein in the 
brain (Dadas et al. 2016; Lobzin et al. 2018). New research 
in the physiology of CSF circulation may also open up new 
possibilities in understanding other neurodegenerative di-
seases in which defective accumulation of neurotoxic depo-
sits contributes to the development of the disease.
Features of the optic nerve and 
ocular cribriform plate from the 
glymphatic system point of view
The optic nerve, the white matter tract of the central ner-
vous system (CNS), is surrounded by all three meninges 
and cerebrospinal fluid in the subarachnoid space (SAP) 
with a pressure equivalent to IOP (Wostyn et al. 2015, 
2017). The movement of CSF on the outer side of the optic 
nerve has been studied quite fully. When tracers are intro-
duced into the cisterna magna or lateral ventricles, they 
are found in or around the optic nerve itself. Thus, in addi-
tion to IOP, the optic nerve is affected by ICP (Wostyn et 
al. 2017). The cribriform plate is a cribriform structure at 
the back of the sclera that allows for the passage of RGC 
axons and central retinal vessels. It separates these two 
areas under pressure and forms a pressure barrier between 
the high-pressure area of the intraocular space and the 
low-pressure area of the retrobulbar space of CSF. The for-
ces acting on the optic disk are influenced by both IOP and 
ICP. The difference between rear-facing IOP and front-fa-
cing IСP passing through the cribriform plate is known as 
the pressure difference of the cribriform plate. The pressu-
re drop in the area of the cribriform plate increases with an 
increase in IOP or a decrease in ICP (Wostyn et al. 2017).
Morphological and functional 
criteria of the intraocular 
glymphatic system
In 2015, researchers from England (Denniston and Kea-
ne 2015) and a research group from Antwerp University 
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Hospital (Wostyn et al. 2015) independently hypothe-
sized the existence of a paravascular transport system 
in the retina and optic nerve, similar to the described 
glyphatic system in the brain. Two years later, the lat-
ter (Wostyn et al. 2017) published a comprehensive re-
view of the recent studies which supports the hypothesis 
that there is a ”glymphatic system” in the eye and optic 
nerve, similar to the described “glymphatic system” in 
the brain. In their opinion, clarification of the glymp-
hatic clearance pathway in the eye may provide a new 
unifying hypothesis for glaucoma, which may include 
many aspects of vascular, biomechanical, and bioche-
mical theories of the disease.
Clinical evidence and applied 
aspects of the glymphatic system 
hypothesis
Many clinical and epidemiological data show that there 
is a similarity between glaucomatous optical neuropathy 
and Alzheimer’s disease, for which the pathogenetic role 
of glymphatic clearance disorders is almost postulated 
(Dadas et al. 2016, Lobzin et al. 2018).
Several studies have found an increased prevalence 
of patients with AD. In their study in a nursing home in 
Germany, Bayer et al. (2002) studied 112 patients with 
AD and 116 patients in the control group. The preva-
lence of POAG was 25.9% in patients with AD and 
5.2% in the control group. In a Japanese study, Tamura 
H et al. (2006) found a prevalence of POAG in 23.8% 
of 172 patients with AD, which was significantly higher 
than 9.9% among 176 patients in the control group. This 
prevalence of glaucoma among patients with AD, com-
bined with multiple similarities between the two diseas-
es, raised the question of whether AD and glaucoma may 
have a common pathogenesis (Bizrah et al. 2011). It is 
important to note that the concentration of Aß increases 
with a chronic increase in IOP in animals with experi-
mentally induced ocular hypertension, which causes the 
death of retinal ganglion cells (Ito et al. 2012). Glym-
phatic pathway dysfunction as a potential mechanistic 
link between AD and glaucoma is an important hypoth-
esis, as it may explain the comorbidity of these two dis-
orders. The results showed that in glaucoma, ther is an 
IOP-sensitive increase in Aß. McKinnon et al. (2002) 
reported that the retinal ganglion cells of rats subjected 
to a chronic increase inIOP showed caspase-3-mediated 
abnormal processing of the β-amyloid precursor (APP) 
with an increased Aß expression. This suggests a new 
hypothesis of ganglion cell death in glaucoma involving 
chronic Aß neurotoxicity that mimics AD at the molecu-
lar level (Mancino et al. 2018).
Increasing evidence indicates that intracranial pressure 
is lower in patients with POAG compared to non-glauco-
matous control groups. In addition, ICP has been reported 
to be lower at normal tension compared to the high-ten-
sion form of POAG (Berdahl and Allingham 2010). If ICP 
is too low, the flow of fluid from the paravascular spaces 
in the optic nerve to the paravascular spaces in the retina 
may decrease or stop, considering that this paravascular 
flow must cross the IOP-ICP pressure barrier. There are 
also specific cases indicating the role of cerebral para/
perivascular (Virchow-Roben) spaces as an indicator of 
glymphatic clearance dysfunction in primary open-angle 
glaucoma (Wostyn et al. 2016).
In an experimental study of retinal ischemia-reperfu-
sion, a simulated mechanical pressure of up to 110 mm 
Hg was reproduced in the anterior chamber of the eye 
for 30 minutes (Peresypkina et al. 2017), as a result of 
which we found pronounced microcirculatory disorders 
and destructive neuronal changes with the highest vul-
nerability of the retinal ganglion layer. In addition, there 
were obvious changes in paravascular structures near 
the cribriform plate and inside the optic nerve (unpub-
lished data). Periarterial spaces were extremely enlarged 
and edematous. Internal structure of the optic nerve with 
a marked weakening of the interstitial and perivenular 
edematous space (Fig. 1).
Figure 1. Changes in the optic disk area in simulated hyper-
tensive retinopathy: a, b – marked enlargement and edema of 
the periarterial spaces; c – enlargement of the perivenular space 
(vertical arrow) and a decrease in interstitium in the optic nerve. 
Stained with hematoxylin-eosin. Scanned slide. Magnification 
of ×400 (according to unpublished data). These results may re-
flect an overloaded state of perivascular structures and, on the 
other hand, serve as our own evidence that intraretinal glym-
phatic structures are associated with passages for fluid transport 
within the optic nerve.
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Conclusion
The theory of transport and clearance of the brain pa-
renchyma has a lot of evidence that makes it possible to 
apply it to the nutritional and cleansing mechanisms in 
the optic nerve and retina. The existence of the glymp-
hatic pathways of the optic nerve and retina is confir-
med by the structural similarity between the meninges 
and optic neural brain complexes, the coexistence of pa-
thologies associated with glymphatic system dysfuncti-
on (AD, glaucoma) and experimental data. Further stu-
dies of the morphofunctional basis of the paravascular 
system of the eye and its changes in simulated glauco-
ma are important and promising for advancing the un-
derstanding of glaucoma pathology and developing an 
appropriate therapy.
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